Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)

CUSIP: 86150R107

Q1 2025 13F Holders as of 31 Mar 2025

Security identity
Shares outstanding
58,810,778
Holder snapshot
Share change
+5,323,878
Put/Call ratio
4879%
Reported price per share
$6.65
Number of holders
124
Value change
+$30,343,505
Number of buys
68
Number of sells
55

Security key

86150R107

Report period

Q1 2025

Institutions

124

Top holders

10

Ownership snapshot

Top reported holders of STOK - Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
MORGAN STANLEY
13D/G signal
MORGAN STANLEY
Evidence rows
15
Latest as of
31 Dec 2024
13F 13D/G Lead comparable stake: 6.5% 13D/G row: MORGAN STANLEY Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
MORGAN STANLEY
13F 13D/G
Company
6.5%
from 13D/G
$37,912,800
3,437,244 shares
31 Dec 2024
Skorpios Trust
13F
Company
13F
12%
$76,175,176
6,906,181 shares
31 Dec 2024
BlackRock, Inc.
13F
Company
13F
10%
$64,939,246
5,887,511 shares
31 Dec 2024
Lynx1 Capital Management LP
13F
Company
13F
8.8%
$57,214,717
5,187,191 shares
31 Dec 2024
RTW INVESTMENTS, LP
13F
Company
13F
8.7%
$56,512,481
5,123,525 shares
31 Dec 2024
BAKER BROS. ADVISORS LP
13F
Company
13F
7.9%
$51,111,233
4,633,838 shares
31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
124
Shares
63,384,229
Rows available
124
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
129
Q1 2025 holders
124
Holder diff
-5
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .